Mercy Health is committed to offering clinical trials to patients suffering from cardiac diseases and disorders. We are currently seeking qualified candidates for the following cardiology research studies available through Mercy Health:

Cardiology Clinical Trials

Atrial Fibrilation
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients with Atrial Fibrillation (Phase II/III)
Study Number: NCT01468701
Please call 419-251-4919 to learn more.

Product Surveillance Registry
Study Number: NCT01524276
Please call 419-251-4919 to learn more.
Principal Investigator: Ameer Kabour, MD

Biotronik - A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - Bioflow-V
Study Number: NCT02389946
Please call 419-251-4919 to learn more.

Randomized Controlled Trial Clinical Evaluation of the ABSORB™ Bioresorbable Vascular Scaffold (BVS) in the Treatment of Subjects with de novo Native Coronary Artery Lesions
Study Number: NCT01751906
Please call 419-251-4919 to learn more.

If you believe that you would be a strong candidate for one of our cardiology clinical trials, please reach out to the contacts listed above. Participating in medical trials gives you access to new or emerging treatment options that are not yet widely available, and allows you to help push medical research forward in the process.

Why Choose Mercy Health?
Mercy Health physicians and healthcare professionals are conducting medical research to help patients live healthier and longer. They are committed to making lives better—mind, body and spirit.